During the past decade, Princess Maxima Center for Pediatric Oncology conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.3% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princess Maxima Center for Pediatric Oncology" #1 sponsor was "Gustave Roussy, Cancer Campus, Grand Paris" with 3 trials, followed by "Nationwide Children's Hospital" with 3 trials sponsored, "University of Birmingham" with 3 trials sponsored, "Charite University, Berlin, Germany" with 2 trials sponsored and "Eli Lilly and Company" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princess Maxima Center for Pediatric Oncology" #1 collaborator was "Australian & New Zealand Children's Haematology/Oncology Group" with 3 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Cancer Research UK" with 2 trials as a collaborator, "Centre Hospitalier Universitaire de Nice" with 2 trials as a collaborator and "Children's Hospital Colorado" with 2 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 100 trials.

According to Clinical.Site data, the most researched conditions in "Princess Maxima Center for Pediatric Oncology" are "Acute Lymphoblastic Leukemia" (4 trials), "Acute Myeloid Leukemia" (4 trials), "Acute Lymphoblastic Leukemia (ALL)" (2 trials), "Cerebral Adrenoleukodystrophy (CALD)" (2 trials) and "Diffuse Intrinsic Pontine Glioma" (2 trials). Many other conditions were trialed in "Princess Maxima Center for Pediatric Oncology" in a lesser frequency.

Most popular intervention types in "Princess Maxima Center for Pediatric Oncology" are "Drug" (38 trials), "Radiation" (6 trials), "Biological" (5 trials), "Procedure" (4 trials) and "Genetic" (3 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (7 trials), "Doxorubicin" (5 trials), "Etoposide" (5 trials), "Cytarabine" (4 trials) and "Fludarabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Princess Maxima Center for Pediatric Oncology" are 44 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Princess Maxima Center for Pediatric Oncology". undefined are not yet recruiting, 28 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Princess Maxima Center for Pediatric Oncology, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Princess Maxima Center for Pediatric Oncology, 14 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".